Stocks to buy in the US in the anticipated correction (page 1 of 4)
- Tuesday, January 15 - 2002 at 14:50
Look for values after any significant corrections and accumulate stocks with proven track record. This week the earnings-reporting season will start in earnest.
We shall see whether the past 3-½ month rise in share prices is justified given the outlook for profits. The recommendation is to look for values after any significant corrections and accumulate stocks with proven track records and franchise that offer an investment return of 10% or better in the next 12 months.
The stocks on our watch list are:
Disney (DIS $21.87) - with mounting debt and plummeting cash flow, management is increasingly under pressure to turn the company's fortune around, if they cannot deliver, it will not be a surprise that Disney will be a takeover target. Using normalized earnings of $0.82, the P/E of Disney is around 26x at current price, and P/B is less than 2x. Therefore, we would suggest accumulating the stock between $18 to $20.
Exxon Mobil (XOM $38.50) - the current EV/EBITDA is 8x, its return on capital continues to be over 2x the weighted average cost of capital. Historically, oil prices have been in the range of $18 to $22, and current oil price is at $20. The levels considered to accumulate the stock are at or below $36.
Dupont (DD $43.02) - after a disastrous venture into genetically modified food, the company is refocusing on its core competency of polymer chemistry, which brought us nylon, Lycra, Teflon, & Kevlar, with a new focus on bio-based materials. The company is putting effort to combine traditional chemistry with biology to create new bio-based materials. That is combining basic chemical processing capability and fundamental engineering skills together with genetics to create new technology platforms. See a good buying opportunity in the $36 to $38 range.
JP Morgan Chase (JPM $38.34) - price will be plagued by the failure of Argentina and Enron in the short term. CSFB expects JPM's risk related to Argentina is now in the range of $1billion-$1.5billion, and $2.6billion in Enron. The total is less than 0.5% of its total asset. JPM will recognize $455 million losses in the 4Q, when it reports on Jan-16-02. Current expectations are low, and is a recovery play once the capital markets and economy pick up. Buying range $32 to $35.
US Technology
Last week's trading activities were largely dominated by news in the semiconductor industry. While the news were fundamentally positive, semiconductor stocks sold-off as investors locked-in short-term capital gains. On a week-on-week basis, the Philadelphia Semiconductor Index fell 3.5% to 568.89 on profit-taking from the previous week's strong 9.4% up-move. We believe the memory segment within the semiconductor industry is still in a consolidation phase, with demand and supply issues showing signs of stabilising. Encouraging developments within the industry include a potential agreement between Micron Technologies (MU US, $35.13, CSFB rating: Hold) and Hynix Semiconductor (0066 KS, Won3,165, CSFB rating: Hold) that is viewed as positive as the global supply of memory chips will be further streamlined and controlled by a few major producers (thus avoiding excess supply). Also, with the unexpected up-tick in demand for memory chips, investors have begun to focus on Samsung Electronics (0593 KS, Won306,000, CSFB rating, Strong Buy) to see if the company will be successful in increasing contract prices again. Conclusion: Turning slightly positive on the sector.
Our stance towards the technology sector remains unchanged. We are still cautious. The next two weeks earnings season will provide some indications on which business is recovering and which requires more patience.
Article Options
Disclaimer »
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.

Credit Suisse, Private Banking



